Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Findings from a global cohort of patients harbouring germline pathogenic/likely pathogenic variants in BRCA1 or BRCA2
New indication concerns treatment of adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy
Evidence for efficacy is based on the results from the DESTINY-Breast06 study
Findings from a systematic review of published studies
Findings from the PEACOCC study
Findings from the CEPHEUS study
New indication concerns treatment of adult patients with relapsed or refractory follicular lymphoma after at least two lines of systemic therapy
Evidence for efficacy is based on the results from the TROPION-Breast01 study
Findings from updated analysis of the ShortHER study
Findings from the AMPLIFY study
Findings from the CheckMate 816 study
Evidence for efficacy is based on the results from the ECHO study
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
